(687.3) Pharmacological Inhibition of Cullin Neddylation Improves Hepatic Insulin Sensitivity

Poster Board Number: D27

Lijie Gu (The University of Oklahoma Health Sciences Center, The University of Oklahoma Health Sciences Center), Cheng Chen (The University of Oklahoma Health Sciences Center), David Matye (The University of Oklahoma Health Sciences Center), Mohammad Hasan (The University of Oklahoma Health Sciences Center), Yung-Dai Clayton (The University of Oklahoma Health Sciences Center), Tiangang Li (The University of Oklahoma Health Sciences Center)

Background and significance. Hepatic insulin resistance is a hallmark feature of non-alcoholic fatty liver disease (NAFLD) and type-2 diabetes (T2D) and significantly contributes to systemic insulin resistance. Abnormal activation of nutrient and stress-sensing kinases leads to serine/threonine phosphorylation of insulin receptor substrate (IRS) and subsequent IRS proteasome degradation, which is a key underlying cause of hepatic insulin resistance. Recently, members of the cullin-RING E3 ligases (CRLs) have emerged as mediators of IRS protein turnover. CRLs are activated upon cullin neddylation, a process of covalent conjugation of a ubiquitin-like protein called Nedd8 to a cullin scaffold. 

Aim. To investigate the role of CRLs in regulating hepatic insulin signaling in NAFLD. 

Methods. Neddylation inhibitor MLN4924 was used to study its effect on insulin sensitivity in liver cells. Hyperinsulinemic-euglycemic clamp was used to assess MNL4924 effect on insulin sensitivity in vivo. siRNA-mediated screening was used to identify the Cullin members that mediates IRS protein turnover in liver cells. Co-immunoprecipitation was performed to study Cullin and IRS interaction. Glucose homeostasis and insulin sensitivity were studied in mice with AAV-mediated liver specific knockdown of Cul1 or Cul3.

Results. Neddylation inhibition delays CRL-mediated IRS protein turnover to prolong insulin action in cultured liver cells. Consistently, acute MLN4924 treatment rapidly decreases hepatic glucose production without causing hypoglycemia in mice, while chronic MLN4924 treatment completely normalizes hyperglycemia in obese mice independent of obesity. Hyperinsulinemic-euglycemic clamp study revealed that MLN4924 significantly increased insulin sensitivity and improved hepatic glucose output. In vitro siRNA based screening showed that knockdown of Cul1 or Cul3, but not other cullin family members, stabilized IRS protein and increased insulin sensitivity in AML12 cells. Consistently, Co-immunoprecipitation demonstrated IRS interaction with Cul1 and Cul3. AAV-mediated liver specific knockdown of Cul1 in mice improved insulin sensitivity, lowered fasting glucose, and prevented Western diet-induced obesity and NAFLD. In contrast, AAV-mediated liver Cul3 knockdown only decreased fasting glucose in chow-fed mice but not Western diet-fed mice. 

Conclusion:  These findings suggest that pharmacological inhibition of cullin neddylation is a novel therapeutic strategy for hepatic insulin sensitization in NAFLD and T2D. This effect may be at least in part mediated by hepatic Cul1 and Cul3 neddylation.